VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TLSA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TLSATiziana Life Sciences Ltd
$1.23$78M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTLSAQuarterly Financials

Tiziana Life Sciences Ltd (TLSA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Tiziana Life Sciences Ltd (TLSA) quarterly income statement — complete revenue, gross profit & net income history

TLSA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16Q2'16
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold146K88K61K126K41K-51.92K56.54K-55.84K077.77K45.7K44.07K245.47K260.03K7.77K8.25K5.96K4.86K00
COGS % of Revenue--------------------
Gross Profit-146K-88K-61K-126K-41K-55K-56.54K55.84K0-77.77K-45.7K-44.07K-245.47K-260.03K-7.77K-8.25K-5.96K-4.86K00
Gross Margin %--------------------
Gross Profit Growth %-139.34%30.16%-48.78%-129.09%27.48%-198.5%-171.8%100%-76.45%81.38%83.05%-3060%-3051.85%-30.42%-69.72%----
Operating Expenses12.18M8.87M9.13M12.76M6.19M14.93M12.28M5.57M2.25M21.14M25.34M5.06M4.54M4.63M4.75M2.29M1.93M1.79M1.93M1.06M
OpEx % of Revenue--------------------
Selling, General & Admin5.15M5.63M6.48M7.61M1.37M-1.73M5.53M-5.46M1.47M15.09M5.71M1.96M-1.25M1.24M1.24M-565.82K-430.69K-549K-549K688K
SG&A % of Revenue--------------------
Research & Development7.04M3.24M2.65M5.15M4.83M4.16M6.75M9.06M3.73M6.05M2.8M469.04K1.86M1.84M1.84M2.85M2.17M2.34M2.34M1.48M
R&D % of Revenue--------------------
Other Operating Expenses000001000K01000K-1000K01000K1000K1000K1000K1000K0187.53K0147.5K-1000K
Operating Income-12.33M-8.96M-9.19M-12.89M-6.23M-14.88M-12.34M-5.52M-5.2M-21.22M-25.38M-5.11M-4.98M-4.93M-4.92M-5.14M-3.91M-4.12M-4.12M-3.64M
Operating Margin %--------------------
Operating Income Growth %-34.1%30.5%-47.49%13.4%49.49%-169.66%-137.12%73.99%79.5%-315.3%-409.5%-3.72%-1.19%4.16%-25.85%-24.65%5.12%-13.14%-75%-86.78%
EBITDA-12.18M-8.87M-9.13M-12.76M-6.19M-14.81M-12.28M-5.51M-5.2M-21.14M-25.34M-5.06M-4.85M-4.8M-4.8M-5.13M-3.91M-4.12M-4.12M-3.64M
EBITDA Margin %--------------------
EBITDA Growth %-33.4%30.5%-47.48%13.85%49.59%-168.7%-136.15%73.92%79.47%-317.38%-421.87%-5.51%-1.19%6.45%-22.84%-24.62%5.14%-13.12%-15.49%
D&A (Non-Cash Add-back)146K88K61K126K41K69.65K56.54K6.07K2.5K77.77K45.7K44.07K126.89K125.47K125.4K8.28K6.3K5.5K5.5K4K
EBIT-12.33M-5.63M-8.76M-15.96M-8.62M-10.91M-13.37M-5.48M-5.2M-21.22M-25.38M-5.11M-4.98M-4.93M-4.92M-5.14M-3.91M-4.12M-4.12M-3.64M
Net Interest Income-4K5K696K224K1.15M-6.33K-8.6K0-56-25K-310.77K-6.3K-84.34K-6.47K-6.47K-5.5K-4.96K-3.89K-8.5K4K
Interest Income14K5K702K224K1.15M000007.83K01.26K0000000
Interest Expense18K06K05K6.33K8.6K0025K318.6K6.3K85.6K6.47K6.47K5.5K4.96K3.89K4.5K4.5K
Other Income/Expense-471K3.32M427K-3.07M-2.39M3.97M-1.04M40.06K2743.74M1.7M154.89K-46.78K-46.26K-46.23K-5.69K-4.33K-4.5K-4.5K4K
Pretax Income-12.8M-5.63M-8.77M-15.96M-8.63M-10.91M-13.38M-5.48M-4.83M-17.48M-23.68M-4.95M-5.03M-4.97M-4.97M-5.15M-3.92M-4.13M-4.13M-3.65M
Pretax Margin %--------------------
Income Tax00-1.56M-6.65M449K00000-2.24M0-346.08K-342.2K-342.01K-1.01M-766.8K-742.5K-742.5K-44.5K
Effective Tax Rate %0%0%17.76%41.68%-5.21%0%0%0%0%0%9.48%0%6.88%6.88%6.88%19.58%19.58%17.99%17.99%1.22%
Net Income-12.8M-5.63M-7.21M-9.31M-9.07M-10.91M-13.38M-5.48M-3.21M-17.48M-21.43M-4.95M-4.68M-4.63M-4.63M-4.14M-3.15M-3.38M-3.38M-3.6M
Net Margin %--------------------
Net Income Growth %-77.54%39.49%20.55%14.7%32.17%-99.19%-316.96%68.66%85.03%-252.85%-357.73%-7%-1.19%-11.89%-46.92%-22.24%6.96%6.08%14.52%16.5%
Net Income (Continuing)-12.8M-5.63M-7.21M-9.31M-9.07M-10.91M-13.38M-5.48M-3.21M-17.48M-21.43M-4.95M-4.68M-4.63M-4.63M-4.14M-3.15M-3.38M-3.38M-3.6M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.22-0.10-0.13-0.18-0.18-0.20-0.28-0.10-28.90-0.24-0.24-0.07-0.07-0.07-0.07-0.06-0.05-0.06-0.06-0.08
EPS Growth %-69.23%46.44%27.78%10%35.71%-105.76%99.03%59.5%-11941.67%-263.64%-250.88%2.94%-0.89%-5.26%-37.8%-1.57%22.64%17.62%26.05%18.57%
EPS (Basic)-0.22-0.10-0.13-0.18-0.18-0.20-0.28-0.10-28.90-0.24-0.24-0.07-0.07-0.07-0.07-0.06-0.05-0.06-0.06-0.08
Diluted Shares Outstanding59.47M58.41M54.56M51.55M51.33M50.76M50.29M50.76M110.82M75.11M44.39M75.11M68.24M68.24M68.24M63.78M63.78M53.2M53.2M46.8M
Basic Shares Outstanding59.47M58.41M54.56M51.55M51.33M50.76M50.29M50.76M110.82M75.11M44.39M75.11M68.24M68.24M68.24M63.78M63.78M53.2M53.2M46.8M
Dividend Payout Ratio--------------------